New-onset refractory status epilepticus/febrile infection-related epilepsy syndrome centers of excellence: A framework for coordinated care, research, and improved outcomes.
AuteursEschbach K, Fisher KS, Haider HA, Casas D, Gaspard N, Gilmore EJ, Gofton T, Gopaul MT, Hirsch LJ, Muscal E, Riviello JJ, Sheikh ZB, Stredny CM, Taraschenko O, Wickström R, Wong N, Lai YC
Plasma CXCL13 and fibrosis biomarkers in COVID-19 compared with idiopathic pulmonary fibrosis.
AuteursGendron N, Rial C, Massonnaud CR, Nguyen A, Philippe A, Rus K, Nunes H, Sanchez O, Diehl JL, Peiffer-Smadja N, Hites M, Rancic J, Yazdanpanah Y, Mentré F, Ader F, Israel-Biet D, Espitia O, Smadja DM
Acute brain dysfunction clusters in COVID-19: a pilot machine learning-based analysis of the COVID-D cohort.
AuteursRomero-García N, Montosa-I-Micó V, Fernández-Narro D, García-Gómez JM, Hurtado L, Passariello E, Taccone FS, Robba C, Raman R, Orun OM, Pandharipande P, Pun BT, Ely EW, Badenes R, Sáez C
Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAID.
AuteursAmiot A, Ahres A, Stefanescu C, Meyer A, Nachury M, Nancey S, Richard N, Allez M, Altwegg R, Laharie D, Serrero M, Franchimont D, Hupé M, Fumery M, Vuitton L, Nahon S, Gilletta C, Rouillon C, Nuzzo A, Berre CL, Caron B, Buisson A, Amil M, Charkaoui M, Cadiot G, Caillo L, Simon M, Reenaers C, Hébuterne X, Plastaras L, Atanasiu C, Kwiatek S, Uzzan M, Pelletier AL, Benezech A, Vidon M, Goutorbe F, Geyl S, Cellier C, Montuclard C, Moussata D, Seksik P
